| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.57B | 116.42B | 117.13B | 117.14B | 104.45B | 76.60B |
| Gross Profit | 10.47B | 12.98B | 14.01B | 12.43B | 10.20B | 8.01B |
| EBITDA | 7.45B | 10.03B | 11.34B | 10.10B | 7.91B | 4.94B |
| Net Income | -574.00M | 3.23B | 3.12B | 2.90B | 2.57B | 897.00M |
Balance Sheet | ||||||
| Total Assets | 171.35B | 203.49B | 204.74B | 213.24B | 208.29B | 195.24B |
| Cash, Cash Equivalents and Short-Term Investments | 6.46B | 44.14B | 43.11B | 63.48B | 62.40B | 62.62B |
| Total Debt | 14.90B | 18.31B | 16.66B | 29.67B | 26.18B | 22.14B |
| Total Liabilities | 37.59B | 45.27B | 50.34B | 60.14B | 57.26B | 46.73B |
| Stockholders Equity | 131.53B | 155.99B | 152.19B | 150.98B | 148.65B | 146.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 154.00M | -4.28B | 1.32B | -1.63B | -7.15B |
| Operating Cash Flow | 0.00 | 7.61B | -1.07B | 5.09B | 2.93B | 4.19B |
| Investing Cash Flow | 0.00 | -5.88B | -2.92B | -3.76B | -4.33B | -10.98B |
| Financing Cash Flow | 0.00 | -1.47B | -16.63B | -749.00M | 821.00M | -4.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥354.25B | 12.83 | ― | 3.26% | -7.77% | 58.84% | |
74 Outperform | ¥215.58B | 14.50 | 6.87% | 5.25% | -1.43% | 171.44% | |
73 Outperform | ¥194.06B | 7.83 | 7.36% | 3.42% | -18.72% | -25.26% | |
70 Outperform | ¥104.34B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
67 Neutral | ¥186.49B | 11.58 | 5.06% | 1.80% | 4.10% | 152.90% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥79.23B | 53.99 | ― | 1.24% | -12.05% | -97.36% |